A bifunctional catalyst composed of ZnGaO with a spinel structure and molecular sieve SAPO-34 catalyses the direct conversion of CO to C-C olefins with a selectivity of 86% and a CO conversion of 13% at 370 °C. The oxygen vacancies on ZnGaO surfaces are responsible for CO activation, forming a methanol intermediate, which is then converted into C-C olefins in SAPO-34.
Transformation
of syngas (H2/CO) and hydrogenation of
CO2 into lower olefins are attractive routes for chemical
utilization of various carbon resources and CO2, but both
suffer from limited product selectivity. Tandem catalysis that integrates
the activation of CO or CO2 to an intermediate and the
subsequent controllable C–C bond formation to form lower olefins
offers a promising approach. Here, we report the hydrogenation of
both CO and CO2 over bifunctional catalysts composed of
a spinel binary metal oxide and SAPO-34. ZnAl2O4/SAPO-34 and ZnGa2O4/SAPO-34 are found to be
highly selective for the synthesis of lower olefins from both CO and
CO2. Our studies reveal that the oxygen vacancy site on
metal oxides plays a pivotal role in the adsorption and activation
of CO or CO2, while the −Zn–O– domain
accounts for H2 activation. We demonstrate that methanol
and dimethyl ether formed on metal oxide are the reaction intermediates,
which are subsequently converted to lower olefins by the Brønsted
acid sites in zeolite. The hydrogenation of CO and CO2 on
metal oxide surfaces proceeds via the same formate and methoxide species.
We elucidate that the water–gas shift reaction on oxide surfaces
is responsible for CO2 formation during syngas conversion.
The cofeeding of CO2 in syngas offers a useful strategy
to inhibit CO2 formation.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.